Study ID: BDP-AR-303
Study Title
- Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 Mcg in Female, Maleergic Rhinitis
Teva Identifier
- BDP-AR-303
ClinicalTrials.gov Identifier
- NCT00988247
Study Status
- Completed
Trial Condition(s)
- Rhinitis, Female, Maleergic, Perennial
Interventions
- Drug: Beclomethasone dipropionate | Drug: Placebo Nasal Aerosol
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 12 Years and older
Trial Duration
- 10/01/2009 - 02/01/2011
Phase
- Phase 3
Study Type
Interventional
